Abstract
New series of 3-arylquinoxaline-carbonitrile derivatives have been synthesized from various 5-substituted or 5,6-disubstituted benzofuroxanes and tested for their in vitro and in vivo activity against the erythrocytic development of Plasmodium falciparum strain with different chloroquine- resistance status. Quinoxaline 1,4-dioxide derivatives showed superior antimalarial activity in respect to reduced quinoxaline analogues. The best activity was observed with nonsubstituted quinoxaline 1,4-dioxides in positions 6 and 7 of the aromatic ring and with a hydrogen or chloro substituent in para position of the phenyl group.
| Original language | English |
|---|---|
| Pages (from-to) | 754-761 |
| Number of pages | 8 |
| Journal | Arzneimittel-Forschung/Drug Research |
| Volume | 55 |
| Issue number | 12 |
| DOIs | |
| State | Published - 2005 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antimalarial agents
- Quinoxaline-carbonitrile derivatives, in vitro and in vivo studies, synthesis
- β-Hernatin
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver